Inovio Pharmaceuticals, Inc. (INO) Stock Overview
Explore Inovio Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Inovio Pharmaceuticals, Inc. (INO)
Key Financials
Key Financials
Market Cap
131.2M
P/E Ratio
-1.69
EPS (TTM)
$-1.16
ROE
-10.06%
INO Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Inovio Pharmaceuticals, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of INO on the NASDAQ shows an RSI of 71.74, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Inovio Pharmaceuticals, Inc.'s NASDAQ-traded stock include a P/E ratio of -1.69 and a market capitalization of 131.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of INO on the NASDAQ.